(Q44771460)

6 December 2017

An evaluation of the efficacy of compound alpha and triclabendazole against two isolates of Fasciola hepatica (English)

1 reference

6 December 2017

1 reference

Fasciola hepatica

1 reference

M McConville

1

1 reference

6 December 2017

G P Brennan

2

1 reference

6 December 2017

A Flanagan

3

1 reference

6 December 2017

H W J Edgar

4

1 reference

6 December 2017

R E B Hanna

5

1 reference

6 December 2017

M McCoy

6

1 reference

6 December 2017

A W Gordon

7

1 reference

6 December 2017

R Castillo

8

1 reference

6 December 2017

A Hernández-Campos

9

1 reference

6 December 2017

I Fairweather

10

1 reference

6 December 2017

12 February 2009

1 reference

6 December 2017

Veterinary Parasitology

1 reference

6 December 2017

162

1 reference

6 December 2017

1-2

1 reference

6 December 2017

75-88

1 reference

Resistance of Fasciola hepatica to triclabendazole and albendazole in sheep in Spain

6 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.02.004

Biochemical indicators of liver injury in calves with experimental fascioliasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.02.004

Treatment of immature and mature Fasciola hepatica infections in sheep with triclabendazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.02.004

Antimalarial chemotherapeutic peroxides: artemisinin, yingzhaosu A and related compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.02.004

Serum gamma glutamyl transpeptidase activity in cattle with induced fascioliasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.02.004

Humoral and cellular immune responses to Fasciola hepatica experimental primary and secondary infection in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.02.004

Activity of oxyclozanide, nitroxynil, clorsulon and albendazole against adult triclabendazole-resistant Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.02.004

Activity of closantel against adult triclabendazole-resistant Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.02.004

The effects of subclinical fasciolosis on hepatic secretory function in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.02.004

Experimental ovine fasciolosis: antipyrine clearance as indicator of liver damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.02.004

Serum and bile antibody responses (IgG and IgA) during subclinical Fasciola hepatica infection in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.02.004

An experimental study on triclabendazole resistance of Fasciola hepatica in sheep.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.02.004

Diagnostic imaging in sheep hepatic fascioliasis: ultrasound, computer tomography and magnetic resonance findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.02.004

Tegumental surface changes in juvenile Fasciola hepatica in response to treatment in vivo with triclabendazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.02.004

The effect of a parenteral ivermectin/closantel injection on the growth and reproductive development of early immature Fasciola hepatica in cattle.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.02.004

Fasciola hepatica: Histology of the testis in egg-producing adults of several laboratory-maintained isolates of flukes grown to maturity in cattle and sheep and in flukes from naturally infected hosts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.02.004

The kinetics of triclabendazole disposition in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.02.004

Synthesis and fasciolicidal activity of 5-chloro-2-methylthio-6-(1-naphthyloxy)-1H-benzimidazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.02.004

Determination of the effective dose of an experimental fasciolicide in naturally and experimentally infected cattle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.02.004

Artemisinins and synthetic trioxolanes in the treatment of helminth infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.02.004

Artesunate and artemether are effective fasciolicides in the rat model and in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.02.004

Activity of artemether and OZ78 against triclabendazole-resistant Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.02.004

Hematological and biochemical changes in organically farmed sheep naturally infected with Fasciola hepatica.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.02.004

Adult triclabendazole-resistant Fasciola hepatica: surface and subsurface tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.02.004

Immature triclabendazole-resistant Fasciola hepatica: tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.02.004

Surface and internal tegumental changes in juvenile Fasciola hepatica following treatment in vivo with the experimental fasciolicide, compound alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.02.004

Pharmacokinetic disposition of triclabendazole in cattle and sheep; discrimination of the order and the rate of the absorption process of its active metabolite triclabendazole sulfoxide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.02.004

Resistance of Fasciola hepatica against triclabendazole in cattle and sheep in The netherlands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.02.004

Resistance-induced changes in triclabendazole transport in Fasciola hepatica: ivermectin reversal effect.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.02.004

Resistance of Fasciola hepatica to triclabendazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.02.004

Host responses during experimental infection with Fasciola gigantica or Fasciola hepatica in Merino sheep I. Comparative immunological and plasma biochemical changes during early infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.02.004

Pharmacokinetic behavior in sheep and cattle of 5-chloro-2-(methylthio)-6-(1-naphthyloxy)-1H-benzimidazole, a new fasciolicide agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.02.004

Triclabendazole-resistant Fasciola hepatica: beta-tubulin and response to in vitro treatment with triclabendazole.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.02.004

The comparative metabolism of triclabendazole sulphoxide by triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.02.004

Some effects of experimental Fasciola hepatica infection in cattle on the serum activities of gamma-glutamyl transpeptidase and glutamic oxaloacetic transaminase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.02.004

Chronic subclinical ovine fascioliasis: plasma glutamate dehydrogenase, gamma-glutamyl transpeptidase and aspartate aminotransferase activities and their significance as diagnostic aids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.02.004

Field trial on the efficacy of an experimental fasciolicide compared with some commercial compounds in naturally infected cattle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.02.004

Efficacy of an experimental fasciolicide against immature and mature Fasciola hepatica in artificially infected calves

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.02.004

Assessment of the main metabolism pathways for the flukicidal compound triclabendazole in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.02.004

Stage-specific differences in fecundity over the life-cycle of two characterized isolates of the liver fluke, Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.02.004

Comparison of modulation of sheep, mouse and buffalo lymphocyte responses by Fasciola hepatica and Fasciola gigantica excretory-secretory products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.02.004

Fasciola hepatica and Fasciola gigantica: comparison of cellular response to experimental infection in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.02.004

10.1016/J.VETPAR.2009.02.004

7 January 2021

Identifiers

DOI

1 reference

6 December 2017

1 reference